320 likes | 428 Vues
Carboxytherapy is a non-surgical procedure that involves injecting carbon dioxide (CO2) under the skin using a fine needle. This innovative therapy is recognized for its ability to enhance blood circulation, improve oxygenation, and promote fat reduction. Developed in the 1930s, it has been utilized to treat conditions such as vascular pathologies, arthritis, erectile dysfunction, and aesthetic issues like cellulite and localized fat. Treatment typically involves multiple sessions, with minimal side effects, making it a valuable option in various medical and cosmetic fields.
E N D
CARBOXITHERAPY What is it? It is a non surgical method which consists of injecting CO2 at subcutaneous level through a very fine needle (3mm) by using an equipment especially designed for regulating the gas exit with a low pressure.
Characteristics of CO2 • Non scent, colorless, soluble in water • Final product of the organic metabolism • High disolution ( 20 times more than O2 in the microcirculation) • Modest transformation in HCO3
Origen of Carboxitherapy • 1930 : France . Gas de Royat. Arteriopaties • 1930 : Argentine Medical Association • 1953: Publication of 20 experienced years with subcutaneous injections
Action mecanisms. • Active Vaso-dilatation • Increment of oxidatve phenomena • Arteriolization of blood (Bohr effect) • Increasing of cellular oxygenation • Lipolitic effect • Sympatic-litic effect
Toxicity • Absence of toxicity with high dose • Absence of increment in the systemic TA • No variations in the systemic partial pressure of O2 and CO2
Medical directions • Angiology: Arteriopaties, microangiopaties • Reumatology: Arthritis • Urology: Erectil disfunction by angiopaties • Dermatology: Psoriasis, ulcers related to microangiopaties.
Therapeutic directions • Vascular and artery pathologies • Acute arthritis • Sports Medicine • Healing defects
Aesthetic indications • Cellulitis • Located adiposity • Pre liposculpture • Pos lipoescuplture
Contraindications • IAM, unstable anginas • ICC • HTA • Acute tromboflebitis • Located Infections • Epilepsy • Pregnancy • Renal and respiratory insufficiencies
Treatment sessions Between 15 and 20 sessions of approximately 10 minutes each, are suggested according to the different cases. The intensity per week is 2 or 3.
Treatment protocol • The suggested dose of CO2 per member should oscillate between 100 and 200 cc. • Divide the treated zone into 4 or 6 quadrants in eah member. It is suggested not to inject more than 30 o 50 cc per zone. • It is convenient to jab in several directions. • Injections should be complemented with manual massages to spread the gas, control the efisema and dicrease the annoyance on the patient
Patient with multiple symmetrical lipomatosis; pre-surgery situation (frontal) Patient with multiple symmetrical lipomatosis; pre-surgery situation (lateral) Clinic cases
. Patient with multiple symmetrical lipomatosis; pos-surgery situation (frontal) Patent with multiple symmetrical lipomatosis; pos surgery situation (lateral) Clinic cases
Figure1. Microphotograph of the abdominal subcutaneous weave on the patient with multiple symmetrical lipomatosis : biopsy before the treatment with CO2 Figure 2. Microphotography of the abdominal subcutaneous weave on the patient with multiple symmetrical lipomatosis : biopsy after the treatment with CO2. The areas of lisis adipocitaries are evident, with conservation of the anatomic integrity of the vascular system. Microphotograph
Bibliography • Hartmann B.R., Bassenge E., Pittler M.: «Effect of carbon dioxide enriched water on the cutaneous mícrocirculation and oxygen tension in the skin of the foot». Angiology, 48, 957, 1997. • Klopstock T., Naumann M., Seibel P., et al.: «Mitocondrial DNA mutations in multiple Symmetric lipomatosis». Mol. Cell. Biochem., 17, 271, 1997. • Savin E., Bailliart O., Bonnin P., et al.: «Vasomotor effects of transcutaneous CO2 in stage. Il peripheral occlusive arterial disease». Angiology, 46, 785, 1995. • Smith P.D., Stadelmann W.K., Wassemann R.J., et al.: «Benign symmetric lipomatosis (Madelung's disease)». Ann. Plast. Surg., 41, 671, 1998. • Stavropoulos P.G., Wouboulis C.C., Trautmann C., et al.: «Symmetric lipomatoses in female patients». Dermatology, 194, 26, 1997.